Cargando…
CDK4/6抑制剂在非小细胞肺癌治疗中的研究进展
Lung cancer is the leading cause of cancer-related death worldwide. Non-small cell lung cancer (NSCLC) accounts for 80%-85% of lung cancer. Malignant tumors can proliferate indefinitely, and cell cycle regulation is abnormal which is one of the characteristics of malignant tumor. Cyclin D-dependent...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118338/ https://www.ncbi.nlm.nih.gov/pubmed/32102134 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.07 |